期刊文献+

11β-羟基类固醇脱氢酶1基因多态性与2型糖尿病相关性研究 被引量:1

原文传递
导出
摘要 目的探讨11β-羟基类固醇脱氢酶1(type111beta-hydroxysteroid dehydrogenase,11β-HSD1)基因rs12086634-G/T和rs846910-G/A多态性与云南汉族人群2型糖尿病(T2MD)的关系。方法提取78例健康对照者和210例T2DM患者基因组DNA,通过基因测序检测11β-HSD15′端-2940多态位点rs846910-G/A、第三内含子+94处rs12086634-G/T基因型及等位基因分布频率。结果云南汉族人群11β-HSD1rs846910-G/A基因型GG、AG和AA在T2DM组和对照组中的频率分别为79.8%/63.2%,17.5%/32.9%,2.6%/3.9%,G/A等位基因频率为88.6%/79.6%,11.4%/20.4%,两组间差异有统计学意义(P<0.05)。rs12086634-G/T基因型GG、GT和TT在两组间分布频率为5.3%/3.9%,27.4%/23.4%,67.3%/72.7%,G/T等位基因频率为19.0%/15.6%,81.0%/84.4%,差异无统计学意义(P>0.05)。结论11β-HSD1rs846910-G/A可能与云南汉族人群T2DM相关,但rs12086634-G/T与T2DM不一定相关。
出处 《中华临床医师杂志(电子版)》 CAS 2009年第11期80-82,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献3

二级参考文献28

  • 1李慧敏,缪珩,耿厚法,鲁一兵,蒋秀琴.肾上腺髓质素基因微卫星多态性与2型糖尿病的关联研究[J].南京医科大学学报(自然科学版),2004,24(4):337-339. 被引量:2
  • 2郭风劲,彭惠民,张政,晏宁.2型糖尿病患者内皮型一氧化氮合酶基因(CA)_n多态性分析[J].中华老年医学杂志,2004,23(7):484-486. 被引量:3
  • 3ANDREWS R C, ROOYACKERS O, WALKER B R. Effects of the 11beta-hydroxysteroid dehydrogenase inhibitor carbenoxolone on insulin sensitivity in men with type 2 diabetes[J].J Clin Endocrinol Metab,2003,88:285-291.
  • 4HERMANOWSKI-VOSATKA A, GERHOLD D, MUNDT S S,et al. PPARalpha agonists reduce 11beta-hydroxysteroid dehydrogenase type 1 in the liver[J]. Biochem Biophys Res Commun,2000, 279:330-336.
  • 5CAO G, LIANG Y, BRODERICK C L,et al. Antidiabetic action of a liver X receptor agonist mediated by inhibition of hepatic gluconeogenesis[J]. J Biol Chem,2003,278:1131-1136.
  • 6MASUZAKI H, TANAKA T, NAKAO K. Novel transgenic mouse model of the metabolic syndrome[J]. Nippon Rinsho,2004,62:1059-1065.
  • 7MORTON N M, PATERSON J M, MASUZAKI H,et al. Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice[J]. Diabetes,2004,53:931-938.
  • 8LIU Y, NAKAGAWA Y, WANG Y,et al. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice[J]. Diabetes,2003,52:1409-1416.
  • 9WHORWOOD C B, DONOVAN S J, FLANAGAN D,et al.Increased glucocorticoid receptor expression in human skeletal muscle cells may contribute to the pathogenesis of the metabolic syndrome[J]. Diabetes,2002,51:1066-1075.
  • 10DAVANI B, KHAN A, HULT M,et al. Type 1 11beta-hydroxysteroid dehydrogenase mediates glucocorticoid activation and insulin release in pancreatic islets[J]. J Biol Chem,2000,275:34841-34844.

共引文献5

同被引文献11

  • 1唐彬,高维国,南海荣,董砚虎.新诊断2型糖尿病患者不同临床表型胰岛素分泌和胰岛素敏感性的研究[J].中国实用内科杂志,2006,26(2):194-196. 被引量:6
  • 2王继荣,李慧敏,张鹏,鲁一兵,蒋秀琴,缪珩.11β-类固醇脱氢酶Ⅰ型基因微卫星多态性与2型糖尿病的相关性研究[J].南京医科大学学报(自然科学版),2006,26(11):1038-1042. 被引量:2
  • 3韩佳琳,张洁.IFH与IPH—2型糖尿病两种不同临床表型的研究[J].临床内科杂志,2007,24(5):358-360. 被引量:1
  • 4Pereira CD,Azevedo I,Monteiro R,et al. 1 lbeta-Hydroxysteroiddehydrogenase type 1: relevance of its modulation in thepathophysiology of obesity, the metabolic syndrome and type 2diabetes mellitus[J]. Diabetes Obes Metab,2012,14(10) :869-881.
  • 5Inder WJ,Obeyesekere VR,Jang C,et al. Evidence for transcript-specific epigenetic regulation of glucocorticoid-stimulated skeletalmuscle 1 lbeta-hydroxysteroid dehydrogenase-1 activity in type 2diabetes[J]. Clin Epigenetics,2012,4(1) ; 1-8.
  • 6Moon SS,Lee YS,Kim JG,et al. Relationship of 1 lbeta-hydroxysteroid dehydrogenase type 1 and hexose - 6 - phosphatedehydrogenase gene polymorphisms with metabolic syndrome andtype 2 diabetes [J]. Endocr J,2011,58(11) : 949-959.
  • 7Baudrand R,Dominguez JM,Carvajal CA,et al. Overexpression ofhepatic 5alpha-reductase and 1 lbeta-hydroxysteroid dehydrogenasetype 1 in visceral adipose tissue is associated with hyperinsulinemiain morbidly obese patients [J]. Metabolism,2011,60 (12) : 1775-1780.
  • 8Nair S,Lee YH,Lindsay RS’et al. 1 lbeta-Hydroxysteroiddehydrogenase Type 1 : genetic polymorphisms are associated withType 2 diabetes in Pima Indians independently of obesity andexpression in adipocyte and muscle[J]. Diabetologia,2004,47(6):1088-1095.
  • 9Karlsson C,Jemas M,01sson B,et al. Differences in associationsbetween HSD11B1 gene expression and metabolic parameters insubjects with and without impaired glucose homeostasis [ J ].Diabetes Res Clin Pract,2010,88(3) :252-258.
  • 10陈江涛,叶萍萍,刘瑞玉.2型糖尿病患者血清VEGF与sVCAM-1水平的变化及其临床意义[J].热带医学杂志,2011,11(2):202-203. 被引量:3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部